Company: TRUE
Filing Date: 2025-11-06
Form Type: 10-Q
Source: 0001327318-25-000065
Chunk: 215

Company: TrueCar, Inc.
Filing Date: 2025-11-06
Form: 10-Q
Item: Part I, Item 8
Chunk 215
---
 indemnities in the future will be material to the Company’s business, financial position, results of operations, or cash flows.

16

6.    Stock-based Awards

Stock OptionsA summary of the Company’s stock option activity for the nine months ended September 30, 2025 is as follows: Number ofOptionsWeighted-Average Exercise PriceWeighted-AverageRemainingContractual Life   (in years)Outstanding — December 31, 20241,318,123 $9.61 3.5Granted— —  Exercised— —  Forfeited/expired(133,625)12.16  Outstanding — September 30, 20251,184,498 $9.33 3.0At September 30, 2025, there was no remaining stock-based compensation expense for unvested stock option awards as all awards have fully vested. For the three months ended September 30, 2025, the Company recorded no stock-based compensation expense for stock option awards given all outstanding awards have fully vested. For the three months ended September 30, 2024, the Company recorded stock-based compensation expense for stock option awards of less than $0.1 million. For the nine months ended September 30, 2025 and 2024, the Company recorded stock-based compensation expense for stock option awards of $0.1 million and $0.2 million, respectively.Restricted Stock UnitsActivity in connection with restricted stock units is as follows for the nine months ended September 30, 2025: Number ofSharesWeighted- Average Grant Date Fair ValueNon-vested — December 31, 20245,482,977 $3.15 Granted3,541,717 3.13 Vested(2,326,378)3.22 Forfeited(823,155)3.23 Non-vested — September 30, 20255,875,161 $3.10 At September 30, 2025, total remaining stock-based compensation expense for non-vested restricted stock units was $17.0 million, which is expected to be recognized over a weighted-average period of 2.7 years. For the three months ended September 30, 2025 and 2024, the Company recorded $2.2 million and $2.0 million in stock-based compensation expense for restricted stock